Alkermes (ALKS) EBIAT (2016 - 2025)
Alkermes (ALKS) has disclosed EBIAT for 16 consecutive years, with $49.3 million as the latest value for Q4 2025.
- On a quarterly basis, EBIAT fell 66.23% to $49.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $241.7 million, a 34.16% decrease, with the full-year FY2025 number at $241.7 million, down 34.16% from a year prior.
- EBIAT was $49.3 million for Q4 2025 at Alkermes, down from $82.8 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $237.1 million in Q2 2023 to a low of -$64.0 million in Q3 2022.
- A 5-year average of $44.1 million and a median of $29.6 million in 2024 define the central range for EBIAT.
- Peak YoY movement for EBIAT: tumbled 21532.84% in 2021, then surged 5229.53% in 2024.
- Alkermes' EBIAT stood at $125.4 million in 2021, then crashed by 122.52% to -$28.3 million in 2022, then surged by 89.92% to -$2.8 million in 2023, then soared by 5229.53% to $146.1 million in 2024, then tumbled by 66.23% to $49.3 million in 2025.
- Per Business Quant, the three most recent readings for ALKS's EBIAT are $49.3 million (Q4 2025), $82.8 million (Q3 2025), and $87.1 million (Q2 2025).